Plasma Clot Retraction Factor, Deficiency Of

Watchlist
Retrieved
2019-09-22
Source
Trials
Genes
Drugs

Newcomb et al. (1967) described an apparently 'new' bleeding syndrome characterized by deep tissue bleeding, poor wound healing, pseudotumor formation, and umbilical cord bleeding. A defect in clot retraction was correctable by a plasma protein. Family studies supported autosomal recessive inheritance.